维生素B3调节线粒体的脆弱性,并预防老年小鼠的玻璃眼
Pete A Williams1, Jeffrey M Harder1, Nicole E Foxworth1
1The Jackson Laboratory, Bar Harbor, ME 04609, USA.
概括
线粒体功能障碍和NAD+水平下降导致与年龄相关的青光瘤. 维生素B3或基因疗法保护了眼睛,高剂量避免了93%的青光眼.
科学领域:
- 眼科 眼科
- 神经科学
- 老年学
背景情况:
- 大眼是一种神经退行性疾病,导致视力丧失,特别是在老年人中.
- 目前还不清楚青光眼发作和与年龄有关的神经元脆弱性的潜在机制.
研究的目的:
- 研究青光眼神经元功能障碍的早期驱动因素.
- 探索尼古丁胺腺素二核酸 (NAD+) 在与年龄相关的神经元脆弱性的作用.
- 评估NAD+前体的治疗潜力和对青光眼的基因疗法.
主要方法:
- 使用易患青光眼的小鼠模型研究与年龄相关的变化.
- 评估了视网膜神经元中的线粒体功能和NAD+水平.
- 服用尼古丁胺 (维生素B3) 和/ 或Nmnat1基因治疗.
- 评估了对青光眼发育的预防和干预作用.
主要成果:
- 线粒体异常被确定为神经元功能障碍的早期驱动因素.
- 视网膜的NAD+水平随着年龄的增长而下降,从而增加了神经元的脆弱性.
- 尼古丁胺 (维生素B3) 和Nmnat1基因治疗显示出显著的保护作用.
- 在最高剂量下,93% 的眼睛被保护免受青光眼的发展.
结论:
- 线粒体功能障碍和NAD+枯竭是与年龄相关的青光瘤的关键因素.
- 维生素B3和Nmnat1基因疗法对预防和治疗眼有很大希望.
- 这些发现支持维生素B3在治疗青光眼和其他与年龄相关的神经退行性疾病方面的治疗潜力.
相关概念视频
Mitochondria
21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K


